论文部分内容阅读
目的:评析BiPAP无创呼吸机治疗慢性阻塞性肺疾病急性加重(AECOPD)合并呼吸衰竭的临床应用价值。方法:选取本院2012年1月-2015年7月收治的AECOPD合并呼吸衰竭患者共112例,将112例患者通过抽号随机分成两组,每组有患者56例;对照组患者使用常规方式联合呼吸兴奋剂进行治疗,观察组患者则在对照组治疗基础之上使用BiPAP无创呼吸机进行治疗。对两组患者的生命体征和血气指标进行比较分析。结果:观察组AECOPD合并呼吸衰竭患者治疗3 d之后,心率、呼吸频率、血氧饱和度、二氧化碳分压、动脉血氧分压、pH值明显优于对照组患者(P<0.05)。结论:对AECOPD合并呼吸衰竭患者使用BiPAP无创呼吸机进行治疗,能够有效改善患者的血气指标和生命体征。
Objective: To evaluate the clinical value of BiPAP noninvasive ventilator in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) combined with respiratory failure. Methods: A total of 112 patients with AECOPD complicated with respiratory failure admitted to our hospital from January 2012 to July 2015 were enrolled. One hundred and twelve patients were randomly divided into two groups according to an abstract, 56 patients in each group. Patients in the control group were treated with conventional methods Combined with respiratory stimulants for treatment, patients in the observation group were treated with BiPAP noninvasive ventilator on the basis of the control group. Two groups of patients with vital signs and blood gas indicators were compared. Results: The heart rate, respiratory rate, oxygen saturation, carbon dioxide partial pressure, arterial partial pressure of oxygen and pH of the observation group were significantly better than those of the control group after 3 days of treatment (P <0.05). Conclusion: The use of BiPAP non-invasive ventilator for AECOPD patients with respiratory failure can effectively improve the blood gas indexes and vital signs of patients.